EAM
EPIX

Eventide Asset Management’s ESSA Pharma EPIX Stock Holding History

Eventide Asset Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,561,251
Closed -$2.84M – 149
2022
Q3 		$2.84M Sell
1,561,251
-1,804,317
-54% -$4.75M 0.06% 131
2022
Q2 		$10.6M Sell
3,365,568
-804,691
-19% -$4.5M 0.23% 96
2022
Q1 		$25.8M Buy
4,170,259
+851,612
+26% +$7.49M 0.4% 75
2021
Q4 		$47.1M Buy
3,318,647
+1,137,546
+52% +$12.7M 0.6% 56
2021
Q3 		$17.4M Sell
2,181,101
-224,068
-9% -$3.56M 0.23% 105
2021
Q2 		$68.7M Hold
2,405,169
– – 0.92% 40
2021
Q1 		$69.9M Buy
2,405,169
+70,000
+3% +$1.63M 1.04% 35
2020
Q4 		$26.5M Hold
2,335,169
– – 0.41% 78
2020
Q3 		$15.3M Buy
2,335,169
+325,000
+16% +$2.21M 0.3% 91
2020
Q2 		$11.8M Hold
2,010,169
– – 0.26% 89
2020
Q1 		$7.64M Hold
2,010,169
– – 0.25% 91
2019
Q4 		$10.5M Hold
2,010,169
– – 0.3% 78
2019
Q3 		$6.44M Buy
2,010,169
+625,000
+45% +$1.54M 0.21% 82
2019
Q2 		$3.22M Buy
1,385,169
+903,198
+187% +$2.23M 0.1% 91
2019
Q1 		$1.65M Buy
481,971
+1
+0% +$4 0.06% 107
2018
Q4 		$1.01M Hold
481,970
– – 0.04% 117
2018
Q3 		$1.49M Sell
481,970
-1
-0% -$3 0.05% 126
2018
Q2 		$1.82M Hold
481,971
– – 0.08% 117
2018
Q1 		$1.83M Buy
481,971
+346,000
+254% +$1.44M 0.09% 116
2017
Q4 		$576K Hold
135,971
– – 0.03% 136
2017
Q3 		$699K Hold
135,971
– – 0.04% 126
2017
Q2 		$1.31M Hold
135,971
– – 0.08% 109
2017
Q1 		$7.41M Hold
135,971
– – 0.49% 57
2016
Q4 		$5.26M Hold
135,971
– – 0.34% 69
2016
Q3 		$6.83M Hold
135,971
– – 0.42% 64
2016
Q2 		$7.37M Hold
135,971
– – 0.45% 62
2016
Q1 		$7.83M Buy
+135,971
New +$8.87M 0.44% 62

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Eventide Asset Management's EPIX Position: Q4 2022 in Review

Eventide Asset Management sold out of ESSA Pharma (EPIX) in Q4 2022, closing a stake of 1,561,251 shares — an estimated $2.84M sold.

Eventide Asset Management first reported a position in EPIX in Q1 2016 and held it in 27 quarters. The position peaked at $69.9M in Q1 2021. 45 funds tracked by Wall St. Rank hold EPIX as of Q4 2022.

  • Eventide Asset Management reported no remaining ESSA Pharma position as of Q4 2022 after selling out during the quarter.
  • Eventide Asset Management sold 1,561,251 ESSA Pharma shares in Q4 2022, an estimated $2.84M.
  • Eventide Asset Management first reported a position in ESSA Pharma in Q1 2016 and held it in 27 quarters.
  • Eventide Asset Management's ESSA Pharma position peaked at $69.9M in Q1 2021.
  • 45 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2022.

Based on Eventide Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.